N
Exchange
—
Entity type
operating
Fiscal year end
Jun 30
Headquarters
DE
Recent Filings
- 10-Q2.9 MBNEXIEN BIOPHARMA, INC.May 14, 6:05 AM ET·0001641172-25-010067
- 10-Q2.9 MBNEXIEN BIOPHARMA, INC.Feb 14, 2:03 PM ET·0001493152-25-006734
- 10-Q2.8 MBNEXIEN BIOPHARMA, INC.Nov 18, 12:57 PM ET·0001493152-24-046468
- 10-K42.0 MBNEXIEN BIOPHARMA, INC.Oct 22, 3:00 PM ET·0001493152-24-041978
- 10-Q28.8 MBNEXIEN BIOPHARMA, INC.May 15, 6:19 AM ET·0001493152-24-019400
- 10-Q3.4 MBNEXIEN BIOPHARMA, INC.Feb 20, 6:19 AM ET·0001493152-24-007096
- 10-Q2.7 MBNEXIEN BIOPHARMA, INC.Nov 14, 5:00 PM ET·0001493152-23-041255
- 10-K4.0 MBNEXIEN BIOPHARMA, INC.Sep 28, 6:06 AM ET·0001493152-23-034480
- 10-Q3.0 MBNEXIEN BIOPHARMA, INC.May 17, 2:24 PM ET·0001493152-23-017925
- 10-Q3.0 MBNEXIEN BIOPHARMA, INC.Feb 8, 6:18 AM ET·0001493152-23-003903
Insiders
10- Aceto Joseph FVP Legal & IP Counsel
- Bankier Alain DDirector
- Clark Courtney LynneDirector
- Friedland JeffreyDirector, Chief Executive Officer, 10% Owner
- Goldfarb Robert IChief Operating Officer
- Greenberg Richard SDirector, EVP and Chairman, 10% Owner
- Heiden IvoDirector, 10% Owner
- Kanativa Inc.10% Owner
- Kanativa USA Inc.10% Owner
- Manganella Frank JVP Corporate Development
Tickers
No tickers on record
Addresses
business
4340 E KENTUCKY AVE SUITE 206
GLENDALE, CO, 80246
mailing
4340 E KENTUCKY AVE SUITE 206
GLENDALE, CO, 80246
Former Names
- Intiva BioPharma Inc.2018-09-12
- Kinder Holding Corp.2017-11-06